Literature DB >> 26685772

A Standard Nonmyeloablative Transplantation Regimen for Adults with Sickle Cell Disease: Are We There Yet?

Matthew M Hsieh1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26685772      PMCID： PMC6513311          DOI： 10.1016/j.bbmt.2015.12.002

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN： 1083-8791            Impact factor:   5.742


× No keyword cloud information.
  4 in total

Review 1.  Curative therapies: Allogeneic hematopoietic cell transplantation from matched related donors using myeloablative, reduced intensity, and nonmyeloablative conditioning in sickle cell disease.

Authors:  Gregory M T Guilcher; Tony H Truong; Santosh L Saraf; Jacinth J Joseph; Damiano Rondelli; Matthew M Hsieh
Journal:  Semin Hematol       Date:  2018-04-25       Impact factor: 3.851

2.  Health-Related Quality of Life and Personal Life Goals of Adults With Sickle Cell Disease After Hematopoietic Stem Cell Transplantation.

Authors:  Agatha M Gallo; Crystal Patil; Tokunbo Adeniyi; Lewis L Hsu; Damiano Rondelli; Santosh Saraf
Journal:  West J Nurs Res       Date:  2018-04-06       Impact factor: 1.967

3.  Bone marrow transplantation for adolescents and young adults with sickle cell disease: Results of a prospective multicenter pilot study.

Authors:  Lakshmanan Krishnamurti; Donna S Neuberg; Keith M Sullivan; Naynesh R Kamani; Allistair Abraham; Federico Campigotto; Wandi Zhang; Thabat Dahdoul; Laura De Castro; Suhag Parikh; Nitya Bakshi; Ann Haight; Kathryn L Hassell; Rebekah Loving; Joseph Rosenthal; Shannon L Smith; Wally Smith; Marcus Spearman; Kristen Stevenson; Catherine J Wu; Christina Wiedl; Edmund K Waller; Mark C Walters
Journal:  Am J Hematol       Date:  2019-02-11       Impact factor: 10.047

4.  Is the Game Over or Starting Again? The Role of the Transplant Team in Genetic Counseling for Adult Sickle Cell Disease Recipients.

Authors:  Pelin Aytan; Çiğdem Gereklioğlu; Mahmut Yeral; Aslı Korur; Süheyl Asma; İlknur Kozanoğlu; Hakan Özdoğu; Can Boğa
Journal:  Turk J Haematol       Date:  2016-12-12       Impact factor: 1.831
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.